Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × Denosumab × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 8 Prostatic Neoplasms 6 Multiple Myeloma 5 Fractures, Bone 4 Neoplasm Metastasis 3 Bone Diseases, Metabolic 3 Spinal Cord Compression 2 Parathyroid Neoplasms 2 Osteoporosis 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Smoldering Multiple Myeloma 1 Paraproteinemias 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplastic Processes 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hyperparathyroidism, Primary 1 Hypercalcemia 1 Humoral Hypercalcemia Of Malignancy 1 Hormone Refractory Prostate Cancer 1 Hodgkin Disease 1

Interventions

pembrolizumab 21 atezolizumab 12 Gemcitabine 12 Nivolumab 10 Cisplatin 10 Docetaxel 8 Carboplatin 8 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 epacadostat 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 enfortumab vedotin 2 cabozantinib 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡